The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, Fortress Biotech Inc (NASDAQ: FBIO) closed at $2.26 up 1.35% from its previous closing price of $2.23. In other words, the price has increased by $1.35 from its previous closing price. On the day, 1.19 million shares were traded. FBIO stock price reached its highest trading level at $2.3 during the session, while it also had its lowest trading level at $2.21.
Ratios:
For a deeper understanding of Fortress Biotech Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.06 and its Current Ratio is at 1.23. In the meantime, Its Debt-to-Equity ratio is 3.38 whereas as Long-Term Debt/Eq ratio is at 3.20.
On August 04, 2022, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $6.
On October 02, 2020, The Benchmark Company started tracking the stock assigning a Buy rating and target price of $9.The Benchmark Company initiated its Buy rating on October 02, 2020, with a $9 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 23 ’24 when ROSENWALD LINDSAY A MD bought 763,359 shares for $1.84 per share. The transaction valued at 1,404,581 led to the insider holds 3,657,264 shares of the business.
ROSENWALD LINDSAY A MD bought 5,000 shares of FBIO for $37,418 on Jul 11 ’24. The President, CEO & Chairman now owns 127,500 shares after completing the transaction at $7.48 per share. On Jul 10 ’24, another insider, Jin David, who serves as the Chief Financial Officer of the company, bought 500 shares for $7.50 each. As a result, the insider paid 3,750 and bolstered with 500 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FBIO now has a Market Capitalization of 62387072 and an Enterprise Value of 12372954. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.05 while its Price-to-Book (P/B) ratio in mrq is 2.95. Its current Enterprise Value per Revenue stands at 0.15 whereas that against EBITDA is -0.137.
Stock Price History:
The Beta on a monthly basis for FBIO is 1.66, which has changed by 0.051886797 over the last 52 weeks, in comparison to a change of 0.24933672 over the same period for the S&P500. Over the past 52 weeks, FBIO has reached a high of $2.89, while it has fallen to a 52-week low of $1.36. The 50-Day Moving Average of the stock is 19.86%, while the 200-Day Moving Average is calculated to be 21.98%.
Shares Statistics:
For the past three months, FBIO has traded an average of 634.52K shares per day and 725290 over the past ten days. A total of 27.58M shares are outstanding, with a floating share count of 20.93M. Insiders hold about 24.17% of the company’s shares, while institutions hold 16.11% stake in the company. Shares short for FBIO as of 1730332800 were 2622535 with a Short Ratio of 4.90, compared to 1727654400 on 2350733. Therefore, it implies a Short% of Shares Outstanding of 2622535 and a Short% of Float of 11.5.
